Fibromyalgia: A critical digest of the recent literature

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.79, 2013, Pages

  Giacomelli, Camillo ^a   Sernissi, Francesca ^a   Sarzi Puttini, Piercarlo ^b   Di Franco, Manuela ^c   Atzeni, Fabiola ^b   Bazzichi, Laura ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Fibromyalgia; Recent literature

Indexed keywords

AMITRIPTYLINE; CXCL11 CHEMOKINE; EOTAXIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 4; LORCASERIN; MAGNESIUM CITRATE; MILNACIPRAN; NALTREXONE; SEROTONIN 2C AGONIST; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UBIDECARENONE; UNCLASSIFIED DRUG; VABICASERIN; YM 348;

ACUPUNCTURE; COGNITIVE THERAPY; COMORBIDITY; DANCE THERAPY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FIBROMYALGIA; HUMAN; IL4 GENE; LOW DRUG DOSE; MASSAGE; MEDICAL RESEARCH; MOLECULAR PATHOLOGY; NERVE CONDUCTION; NONHUMAN; PATIENT ASSESSMENT; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; VARIABLE NUMBER OF TANDEM REPEAT; YOGA;

EID: 84892459453     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. MENZIES V, LYON DE, ARCHER KJ et al.: Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract 2013; 2013: 795784.
2. FENG J, ZHANG Z, WU X et al.: Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS One 2013; 8: e65033.
3. YIGIT S, INANIR A, TEKCAN A, INANIR S, TURAL S, ATES O: Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population. Gene 2013; 527: 62-4.
4. KIM SK, KIM SH, NAH SS et al.: Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population. J Rheumatol 2013; 40: 316-22.
5. MARTíNEZ-JAUAND M, SITGES C, RODRí-GUEZ V et al.: Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 2013; 17: 16-27.
6. SCHMECHEL DE, EDWARDS CL: Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent. Neurotoxicology 2012; 33: 1454-72.
7. KLAVER-KRóL EG, ZWARTS MJ, TEN KLOOSTER PM, RASKER JJ: Abnormal muscle membrane function in fibromyalgia patients and its relationship to the number of tender points. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S44-50.
8. DöNMEZ S, PAMUK ÖN, üMIT EG, TOP MS: Autoimmune rheumatic disease associated symptoms in fibromyalgia patients and their influence on anxiety, depression and somatisation: a comparative study. Clin Exp Rheumatol 2012; 30 (Suppl 74): S65-69.
9. ROUSSOU E, CIURTIN C: Clinical overlap between fibromyalgia tender points and enthesitis sites in patients with spondyloarthritis who present with inflammatory back pain. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S24-30.
10. IANNUCCELLI C, SPINELLI FR, GUZZO MP et al.: Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol 2012; 30 (Suppl. 74): S117-21.
11. WOLFE F, RASKER JJ, HäUSER W: Hearing loss in fibromyalgia? Somatic sensory and non-sensory symptoms in patients with fibromyalgia and other rheumatic disorders. Exp Rheumatol 2012; 30 (Suppl. 74): S88-93.
12. GARCíA JJ, CIDONCHA A, BOTE ME, HINCHADO MD, ORTEGA E: Altered profile of chemokines in fibromyalgia patients. Clin Biochem 2013 Oct 8.
13. OKTAYOGLU P, TAHTASIZ M, BOZKURT M et al.: Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgia. Int J Rheum Dis 2013; 16: 403-7.
14. CORDERO MD, ALCOCER-GóMEZ E, CULIC O et al.: NLRP3 Inflammasome Is Activated in Fibromyalgia: The Effect of Coenzyme Q10. Antioxid Redox Signal 2013 Sep 19.
15. SALAFFI F, SARZI-PUTTINI P: Old and newcriteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S3-9.
16. LAUCHE R, HäUSER W, JUNG E et al.: Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey. Clin Exp Rheumatol 2013; 31 (Suppl. 79): S34-40.
17. VELTRI A, SCARPELLINI P, PICCINNI A et al.: Methodological approach to depressive symptoms in fibromyalgia patients. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S136-42.
18. ALCIATI A, SARZI-PUTTINI P, BATTICCIOTTO A et al.: Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S122-8.
19. BAPTISTA AS, VILLELA AL, JONES A, NATOUR J: Effectiveness of dance in patients with fibromyalgia: a randomized, singleblind, controlled study. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S18-23.
20. MADDALI BONGI S, Del ROSSO A, Di FELICE C, CALà M, GIAMBALVO Dal BEN G: Rességuier method and Qi Gong sequentially integrated in patients with fibromyalgia syndrome. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S51-8.
21. BELTRáN-CARRILLO VJ, TORTOSA-MARTíNEZ J, JENNINGS G, SáNCHEZ ES: Contri butions of a group-based exercise program for coping with fibromyalgia: a qualitative study giving voice to female patients. Women Health 2013; 53: 612-29.
22. CRAMER H, LAUCHE R, LANGHORST J, DOBOS G: Yoga for rheumatic diseases: a systematic review. Rheumatology (Oxford) 2013; 52: 2025-30.
23. LIPTAN G, MIST S, WRIGHT C, ARZT A, JONES KD: A pilot study of myofascial release therapy compared to Swedish massage in fibromyalgia. J Bodyw Mov Ther 2013; 17: 365-70.
24. IANNUCCELLI C, MANNOCCI F, GUZZO MP et al.: Complementary treatment in fibromyalgia: combination of somatic and abdominal acupuncture. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S112-6.
25. BATEMAN L, PALMER RH, TRUGMAN JM, LIN Y: Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study. J Pain Res 2013; 6: 311-8.
26. BERNSTEIN CD, ALBRECHT KL, MARCUS DA: Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium. Expert Opin Pharmacother 2013; 14: 905-16.
27. ANG DC, JENSEN MP, STEINER JL, HILLIGOSS J, GRACELY RH, SAHA C: Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomizedcontrolled trial. Clin J Pain 2013; 29: 747-54.
28. OGINO S, NAGAKURA Y, TSUKAMOTO M et al.: Systemic administration of 5-HT(2C) receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model. Pharmacol Biochem Behav 2013; 108: 8-15.
29. YOUNGER J, NOOR N, McCUE R, MACKEY S: Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum 2013; 65: 529-38.
30. NüESCH E, HäUSER W, BERNARDY K, BARTH J, JüNI P: Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis 2013; 72: 955-62.
31. MARTíN J, TORRE F, PADIERNA A et al.: Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S103-11.
32. BeRNARDY K, KLOSE P, BUSCH AJ, CHOY EH, HäUSER W: Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 2013 Sep 10; 9: ì.
33. CARBONARIO F, MATSUTANI LA, YUAN SL, MARQUES AP: Effectiveness of high-frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. Eur J Phys Rehabil Med 2013; 49: 197-204.
34. VILLAMAR MF, WIVATVONGVANA P, PATUMANOND J, BIKSON M, TRUONG DQ, DATTA A, FREGNI F: Focal modulation of the primary motor cortex in fibromyalgia using 4×1-ring high-definition transcranial direct current stimulation (HD-tDCS): immediate and delayed analgesic effects of cathodal and anodal stimulation. J Pain 2013; 14: 371-83.
35. TAYLOR AG, ANDERSON JG, RIEDEL SL, LEWIS JE, BOURGUIGNON C: A randomized, controlled, double-blind pilot study of the effects of cranial electrical stimulation on activity in brain pain processing regions in individuals with fibromyalgia. Explore (NY) 2013; 9: 32-40.
36. LEE SJ, KIM DY, CHUN MH, KIM YG: The effect of repetitive transcranial magnetic stimulation on fibromyalgia: a randomized sham-controlled trial with 1-mo follow-up. Am J Phys Med Rehabil 2012; 91: 1077-85.
37. BAUDIC S, ATTAL N, MHALLA A, CIAMPI de ANDRADE D, PERROT S, BOUHASSIRA D: Unilateral repetitive transcranial magnetic stimulation of the motor cortex does not affect cognition in patients with fibromyalgia. J Psychiatr Res 2013; 47: 72-7.
38. CORDERO MD, ALCOCER-GóMEZ E, de MIGUEL M et al.: Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia?. Antioxid Redox Signal 2013; 19: 1356-61.
39. HOLTON KF, TAREN DL, THOMSON CA, BENNETT RM, JONES KD: The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S10-17.
40. BAGIS S, KARABIBER M, AS I, TAMER L, ERDOGAN C, ATALAY A: Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol Int 2013; 33: 167-72.
41. HIDALGO-TALLóN J, MENÉNDEZ-CEPERO S, VILCHEZ JS, RODRíGUEZ-LóPEZ CM, CALANDRE EP: Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: an open-label pilot study. J Altern Complement Med 2013; 19: 238-42.
42. HäUSER W, SARZI-PUTTINI P, TöLLE TR, WOLFE F: Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. Clin Exp Rheumatol 2012; 30 (Suppl. 74): S78-87.